obesity, (Shaw, Nelson, & Moore, 2002; Waller et al., 1994) prenatal cigarette smoking, (Kallen, 1999; Karatza et al., 2011; Malik et al., 2008; Maurano et al., 2012; Patel et al., 2012) low folate levels, (Botto, Mulinare, & Erickson, 2003; Czeizel, 1998; Scanlon et al., 1998; ) hyperhomocysteinemia, (Hobbs, Cleves, Melnyk, Zhao, & James, 2005; Verkleij-Hagoort et al., 2006; Wenstrom, Johanning, Johnston, & DuBard, 2001 ) and genetic polymorphisms in metabolic pathways including the folate, homocysteine, and glutathionine/transsulfuration pathways (Chowdhury et al., 2012; Hobbs, Cleves, Karim, Zhao, & MacLeod, 2010 ).
In contrast, the possible influence of paternal environmental and genetic factors on the risk of CHDs is much less investigated. Some of the few studies conducted suggest associations between young or advanced paternal age and increased risk of atrial septal defects, (Lian, Zack, & Erickson, 1986; Olshan, Schnitzer, & Baird, 1994 ) ventricular septal defects, (Lian et al., 1986; Olshan et al., 1994) right ventricular outflow tract defects, (Green et al., 2010) pulmonary valve atresia, (Green et al., 2010) patent ductus arteriosus, (Su, Yuan, Huang, Olsen, & Li, 2015) situs inversus (Olshan et al., 1994) , and CHDs overall in their children (Hollier, Leveno, Kelly, MCIntire, & Cunningham, 2000; Olshan et al., 1994; Yang et al., 2007; Zhan, Lian, Zheng, & Gao, 1991) .
Other studies report no association between paternal age and risk of CHDs in their children (Cedergren, Selbing, & Kallen, 2002; Su et al., 2015; Zhan et al., 1991) . Other paternal exposures associated with increased risk of CHDs in their offspring include cigarette smoking, (Cresci et al., 2011; Deng et al., 2013) alcohol consumption (Ou et al., 2016) and occupational exposure to endocrine disruptors (Cresci et al., 2011; Wang et al., 2015) . Although the specific biological mechanisms are unclear, some hypothesize that these exposures may share a similar mechanism: germline mutations and epigenetic alterations to sperm haploid DNA (Beal, Yauk, & Marchetti, 2017; Kong et al., 2012; Linschooten et al., 2013; Marchetti et al., 2011; Sharma et al., 2015; Wyrobek et al., 2006; Yauk et al., 2007) .
Given that extant environmental exposure may induce changes in paternal DNA that can result in CHDs, we postulated that inherent paternal genetic factors, that is, genetic polymorphisms, may also increase CHD risk. Numerous studies confirm that genetic polymorphisms in maternal and infant genes are directly or indirectly associated with risk of CHDs, particularly genes involved in folate, homocysteine, and transsulfuration pathways (Chowdhury et al., 2012; Hobbs et al., 2010; Zhu et al., 2012) . Conversely, none of the published literature to date in English in PubMed, assess the influence of paternal genetic variants in folate, homocysteine, or transsulfuration pathways and CHD risk in offspring. Thus, we investigated parent-of-origin effect for genetic variants in folate, homocysteine, or transsulfuration pathways and the risk of conotruncal heart defects (CTHD) in offspring.
| MATERIALS AND METHODS
We used data from the National Birth Defects Prevention Study (NBDPS) a population-based, case-control study conducted in the United States to investigate the contribution of genetic, environmental, and behavioral factors on the occurrence of major, non-syndromic birth defects (Yoon et al., 2001) . Methods of the NBDPS have been previously described (Yoon et al., 2001) 
| CTHD ascertainment
For NBDPS, all CHD cases were identified based on having at least one of the following diagnostic procedures: echocardiograms, surgical reports, cardiac catherizations, or autopsies. All diagnostic procedure information was then reviewed by a pediatric cardiologist at each study center to ensure uniform criteria for diagnoses. CHD classification was done by a panel of pediatric cardiologists from each study centers led by a pediatric cardiologist at the Center for Disease Control and Prevention (CDC) using the classification system specifically developed for the NBDPS which incorporates cardiac phenotype, cardiac complexity, and extra-cardiac anomalies (Botto et al., 2007) . In our study, conotruncal defects included truncus arteriosus, interrupted aortic arch type B, transposition of the great arteries, double outlet right ventricle, conoventricular septal defects, tetralogy of Fallot, and pulmonary atresia with ventricular septal defect (Botto et al., 2007) .
| Maternal interview
After informed consent, case mothers completed a one-hour computer-assisted telephone interview administered in English or Spanish (Yoon et al., 2001) . During the interview women were queried about their prenatal exposures and information about the baby's father, including, the father's age, and race, occupation, and health behaviors.
| DNA sample collection
After completing the telephone interview, case families were mailed buccal swab kits for collection of maternal, infant, and paternal DNA samples (Yoon et al., 2001) . DNA sample storage and processing methods for the NBDPS are described in detail in a prior publication (Rasmussen et al., 2002) . All cases who had maternal, paternal, and infant DNA samples available were included in our study.
| Genotyping and quality assessment
Genotyping was conducted on a total of 635 case families using 200 ng of DNA on the Illumina Golden Gate platform (Fan, Chee, & Gunderson, 2006; Tang et al., 2014) . A total of 297 individuals were removed due to study ineligibility (n = 33), high no-call rates (n = 63), or high rates of Mendelian inconsistency (n = 201). To ensure high-quality genotypes, we applied stringent quality control measures and excluded SNPs with obviously poor clustering behavior (60 SNPs), no-call rates >10% (328 SNPs), Mendelian error rates >5% (11 SNPs), MAF <5% (204 SNPs), or significant deviation from Hardy-Weinberg Equilibrium in at least one racial group (p < 10 −4 , 12 SNPs). More detailed information regarding genotyping and quality assessment is described in Tang et al. (2014) . For the current study, the final dataset included 1,298 individuals from 616 case families, each with 921 SNPs.
Thirty-seven percent of the study population were family trio samples.
| Statistical method
Summary statistics were expressed as means (standard deviation) for continuous variables, and counts (percentage) for categorical variables.
To investigate the parent-of-origin effect, a log-linear model was fitted for the counts of each SNP as a function of mating types, maternal genetic effect, infant genetic effect, and imprinting parameter (Weinberg, 1999) . Based on the log-linear model for counts and assuming a Poisson distribution, the imprinting effect was estimated as the relative risk (RR) of a CTHD in a child who inherited a paternally derived copy of the minor allele compared to a child who inherits a copy of the minor allele from the mother. Bonferroni correction was used to adjust for multiple testing. Statistical significance level was set at p < 5.43 × 10 −5
. Data were analyzed using statistical software SAS 9.4 (SAS Institute Inc., Cary, NC) for computing descriptive statistics and PREMIM/EMIM for fitting imprinting models (Howey & Cordell, 2012 ).
| Human subjects review
This study was approved by the University of Arkansas for Medical Sciences' Institutional Review Board and the National Birth Defects Prevention Study with protocol oversight by the CDC, Center for Birth Defects, and Developmental Disabilities. All study participants provided written informed consent and legal guardians provided written informed consent for participants who were minors.
| RESULTS
The distributions of maternal and paternal characteristics of infants with CTHDs are presented in Table 1 . Approximately 70% of the mothers were non-Hispanic white, 27% had a high school education and 28% had some college education; 24% were overweight and 21%
were obese. Fifty-one percent of mothers reported periconceptional use of folic acid, 24.5% consumed alcohol during pregnancy, and 19% smoked cigarettes during pregnancy.
A total of 921 SNPs within 60 genes were included in the final analyses. We observed a statistically significant, decreased risk of CTHDs for paternally derived effects for three SNPs in two genesglutaredoxin (GLRX) and glutathione-disulfide reductase (GSR) ( Table 2 ).
These two genes are involved in numerous cellular metabolic and homeostatic processes including the transsulfuration pathway, oxidative-reduction processes, cellular redox homeostasis, and nucleobasecontaining small molecular interconversion reactions. For a child who inherited a paternally derived copy of the A allele for rs17085159 in the ) compared to a child who inherits the maternal A allele.
For the SNP rs12109442, also in GLRX, the risk of developing a CTHD for a child who inherited the paternal copy of the T allele was 0.27 (95% CI: 0.14, 0.50; p = 2.06 × 10 (Table 2) ; however, the confidence interval contained the null value after the Bonferroni adjustment for multiple comparisons.
| DISCUSSION
Our intent was to determine parent-of-origin effects for genetic variants in folate, homocysteine, and transsulfuration pathways and risk of CTHDs in offspring. Little is known about the role of paternally derived genetic variants on pregnancy outcomes including their role in the etiology of CHDs. In our study, we found no statistically significant increased risk of CTHDs for a child who inherited a paternally derived copy of an allele from a SNP in genes involved in the folate, homocysteine, or transsulfuration pathways compared to a child who inherited a maternal copy of the allele. However, we did identify three SNPs for which there was decreased risk of CTHDs for a child who inherited a paternally derived copy of an allele from rs17085159, (Karlsson et al., 2013) cleft lip with/without palate, (Sull et al., 2009 ) body mass, (Hoggart et al., 2014) , and autism spectrum disorder (Connolly, Anney, Gallagher, & Heron, 2017) .
One type of parent-of-origin effect is genomic imprinting which is a mechanism by which epigenetic modifications lead to silencing of one of the two inherited alleles leading to parental-origin determined expression. There are instances where an expressed gene's parent-oforigin can lead to disease. The most common example of this is in FIGURE 1 Distribution of paternally-derived effects for the SNPs identified from hybrid analyses compared to maternally-derived effects for common variants in genes involved in Folate, Homocysteine, and Transsulfuration pathways and risk of conotruncal heart defects, The National Birth Defects Prevention Study, USA, October 1997-August 2008 births
Prader-Willi syndrome (Shemer et al., 2000) and Angelman syndrome (Buiting, Williams, & Horsthemke, 2016; Shemer et al., 2000) in which either the paternal or maternal locus in region 15q11-13 is silenced or deleted, respectively (Elhamamsy, 2017) . To date, only a handful of imprinted loci have been discovered encompassing a small portion of the human genome. Using the Catalog of Imprinted Genes (Morison, Ramsay, & Spencer, 2005) we discovered that these three SNPs with significant paternal versus maternal effect (rs17085159, rs12109442, and rs11953653) are close (<7 kb) to a known imprinted gene, RHOBTB3 that is paternally expressed in the human placenta (Metsalu et al., 2014) and involved in embryonal development (Salas-Vidal, Meijer, Cheng, & Spaink, 2005) . Because imprinted genes tend to cluster together, it has been efficacious to examine regions within 500 kb of imprinted genes to identify parent of origin effects, therefore, these GLRX SNPs might well be within the imprinted cluster (Kong et al., 2009 ). These findings suggest that the risk of CTHD associated with maternally inherited GLRX SNPs may be linked to the parent-of-origin imprinting of the nearby gene RHOBTB3. While our results are suggestive of this, further study of this region using gene expression profiling of the parental-trio will be necessary to confirm the role of imprinting in CTHD risk. There is also evidence to suggest a genetic basis for CTHDs (Andersen, Troelsen Kde, & Larsen, 2014; Fahed et al., 2013; Gelb & Chung, 2014; Pierpont et al., 2007) but the causal genetic mutation has been identified in only a fraction of cases (Gelb & Chung, 2014) . These results highlight the necessity of further investigating the role of imprinting in human development and as an etiological explanation for CHDs.
The SNP rs7818511 was significant (p = 9.94E −6 ) when comparing paternal versus maternal inheritance. Evaluation of this SNP using the mutation prediction tool Mutation Taster (Schwarz, Cooper, Schuelke, & Seelow, 2014) revealed that this polymorphism may cause splice site changes in the assembly of the Glutathione-Disulfide Reductase (GSR) protein leading to potential haploinsufficiency of the protein product.
GSR is an essential component of the oxidative machinery used in multiple processes in the body. GSR production of glutathione, a significant antioxidant, is crucial to effective host defense against bacterial infections (Yan et al., 2013) . Febrile illness and infections are known risk factors for the development of CHDs and other developmental pathologies (Botto, Lynberg, & Erickson, 2001 ).
Maternal haploinsufficiency of GSR, a critical enzyme of the innate immune system, might predispose the mother to infectious disease, prolonged infection, or allow for disease associated sequela to occur.
Our search of the published English language literature in PubMed to date produced no other studies which conducted parent-of-origin analyses for risk of CHDs as the primary aim. However, one study did conduct parent-of-origin analyses in relation to risk of CHDs as ad hoc analyses. Long, Lupo, Goldmuntz, and Mitchell (2011) assessed the associations between maternal SNPs in folate-related genes and the risk of CTHD and left-sided heart defects. In their analyses they found that the maternal genotype, MTR A2756G, was associated with the studied cardiac defect phenotypes. They then tested for the presence of parental imprinting effects in this genotype using the parent-of-origin likelihood-ratio-test and the log-linear likelihood-ratio-test. The imprinting parameters from the parent-of-origin likelihood-ratio-test were FIGURE 2 Manhattan plot for paternally-derived effects for the SNPs identified from hybrid analyses compared to maternally-derived effects for common variants in genes involved in Folate, Homocysteine, and Transsulfuration pathways and risk of conotruncal heart defects, The National Birth Defects Prevention Study, USA, October 1997-August 2008 Births elevated for both CTHDs and left-sided defects but were not statistically significant (Long, Lupo, Goldmuntz, & Mitchell, 2011) . But the parameter from the log-linear likelihood-ratio-test, for CTHD triads was statistically significant (Im = 2.27, 95%CI: 1.06-4.87; p = 0.03). These findings further support the possibility of parent-of-origin effects in the etiology of CTHDs.
Our study results should be interpreted in consideration of potential limitations. DNA samples were obtained from self-collected buccal cheek cell samples and there was disparate quality of the DNA samples.
Additionally, gene expression data was not available in the case-parental trios to confirm the role of imprinting on CTHD risk. In spite of these limitations our study has several strengths. Our study population is a large population-based, multi-ethnic sample, the CTHDs cases were verified by pediatric cardiologists and there was standardization of the CTHD classification across study centers. We also used a very conservative method (Bonferroni correction) to determine statistical significance.
Although our study did not identify any paternal genetic variants in the folate, homocysteine, or glutathione/transsulfuration pathways that increased risk of CTHDs, we did find suggestive evidence of parent-of-origin effects for maternal genetic variants in the GSR and GLRX genes. Further research with larger sample sizes and multi-omic data is need to validate our findings.
